Medicare Enrolled

Dr. Conrad Nievera, MD

Neurology · Spokane, WA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
400 E 5TH AVE, Spokane, WA 99202
5098382531
In practice since 2006 (20 years)
NPI: 1346292018 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nievera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nievera? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nievera

Dr. Conrad Nievera is a neurology specialist in Spokane, WA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Nievera performed 267 Medicare services across 198 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nievera received a total of $29,489 from 49 pharmaceutical and/or device companies across 391 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nievera is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 267 Medicare services $29,489 industry payments

Medicare Practice Summary

Medicare Utilization ↗
267
Medicare services
Bottom 46% in WA for neurology
198
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~13 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 187 $66 $381
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 57 $38 $269
EEG brain wave monitoring, 41-60 minutes
This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes.
 23 $34 $252
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$29,489
Total received (2018-2024)
Avg $4,213/year across 7 years
Top 10% in WA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
391
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$17,230 (58.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,698 (39.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$561 (1.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,219
2023
$782
2022
$1,627
2021
$2,945
2020
$4,501
2019
$7,690
2018
$8,724

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
LivaNova USA, Inc.
$2,455
JAZZ PHARMACEUTICALS INC.
$250
NS Pharma, Inc.
$125
Alexion Pharmaceuticals, Inc.
$125
HARMONY BIOSCIENCES LLC
$104
Biogen, Inc.
$97
ARGENX US, INC.
$64
Top 3 companies account for 87.9% of 2024 payments
All-time payments by company (2018-2024) ›
Supernus Pharmaceuticals, Inc.
$12,683
LivaNova USA, Inc.
$3,760
NEUROPACE, INC.
$3,429
GENZYME CORPORATION
$881
Biogen, Inc.
$824
Greenwich Biosciences, Inc.
$720
Medtronic USA, Inc.
$705
Alexion Pharmaceuticals, Inc.
$653
JAZZ PHARMACEUTICALS INC.
$618
Novartis Pharmaceuticals Corporation
$398
Teva Pharmaceuticals USA, Inc.
$384
SK Life Science, Inc.
$375
Lilly USA, LLC
$305
Harmony Biosciences LLC
$267
UCB, Inc.
$265
Sunovion Pharmaceuticals Inc.
$247
Eisai Inc.
$235
Acorda Therapeutics, Inc
$235
EISAI INC.
$201
Amneal Pharmaceuticals LLC
$188
Pacira Pharmaceuticals Incorporated
$183
Eli Lilly and Company
$175
ARGENX US, INC.
$163
EMD Serono, Inc.
$154
Biohaven Pharmaceutical Holding Company Ltd.
$153
NS Pharma, Inc.
$125
HARMONY BIOSCIENCES LLC
$123
Amgen Inc.
$114
E.R. Squibb & Sons, L.L.C.
$92
Zogenix Inc.
$91
Amylyx Pharmaceuticals, Inc.
$90
BIOCODEX, INC.
$85
ABBVIE INC.
$79
Avanir Pharmaceuticals, Inc.
$64
Sentynl Therapeutics, Inc.
$60
Neurocrine Biosciences, Inc.
$57
Genentech USA, Inc.
$54
PORTOLA PHARMACEUTICALS, INC.
$48
MITSUBISHI TANABE PHARMA AMERICA, INC.
$31
Ipsen Biopharmaceuticals, Inc
$31
Upsher-Smith Laboratories LLC
$23
Shire North American Group Inc
$18
Lundbeck LLC
$16
Mitsubishi Tanabe Pharma America, Inc.
$16
Grifols USA, LLC
$16
ACADIA Pharmaceuticals Inc
$15
Zyla Life Sciences
$14
Celgene Corporation
$13
CSL Behring
$11
Top 3 companies account for 67.4% of all-time payments
Associated products mentioned in payments ›
ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · APTIOM · AUBAGIO · AUSTEDO · Aimovig · BEVYXXA · BOTOX · Briviact · COPAXONE · Cenobamate · DIACOMIT · DYSPORT · EMGALITY · EPIDIOLEX · Epidiolex · Exparel · Fintepla · Fycompa · GAMMAGARD · GILENYA · Gamunex-C · Hizentra · INBRIJA · INGREZZA · KESIMPTA · LEMTRADA · LUMIZYME · MAYZENT · MS DISEASE STATE · Mavenclad · NUEDEXTA · NUPLAZID · NURTEC ODT · Nuedexta · OCREVUS · ONFI · OXTELLAR XR · QUDEXY XR Topiramate Extended Release Capsules · RADICAVA · RELYVRIO · RNS System · RYTARY · Radicava · Rebif · Repatha · SOLIRIS · SPINRAZA · SPRIX · Soliris · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VILTEPSO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYVGART · Vimpat · WAKIX · Wakix · XCOPRI · ZEPOSIA · ZINBRYTA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (58%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 10% for neurology in WA.

Looking for a neurology specialist in Spokane?
Compare neurologists in the Spokane area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
29
Per 100K population
5.3
County median income
$73,513
Nearest hospital
SHRINERS HOSPITAL FOR CHILDREN
2.3 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Nievera is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 10% of WA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Nievera experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Nievera performed 187 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nievera receive payments from pharmaceutical companies?
Yes. Dr. Nievera received a total of $29,489 from 49 companies across 391 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nievera's costs compare to other neurologists in Spokane?
Dr. Nievera's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nievera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Spokane
Browse neurologists in Spokane ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in WA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in WA
Which WA neurologists receive the most from drug and device companies.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
By company
LivaNova USA, Inc. Payments to Doctors
See all physicians who received payments from LivaNova USA, Inc.
By company
NEUROPACE, INC. Payments to Doctors
See all physicians who received payments from NEUROPACE, INC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →